MKEtamine was developed to improve quality of life for clients who suffer from major depressive disorder, PTSD, postpartum depression, and chronic pain. Over the last two decades, significant amounts of literature have been published supporting the use of ketamine infusions for these disorders. Ketamine is administered in low, sub-anesthetic doses over 45 minute treatment periods. These have been proven to improve quality of life scores in a majority of treated patients. In addition to ketamine infusion services, MKEtamine will also have intravenous (IV) hydration therapies. This includes a variety of IV mixtures to improve overall wellness. MKEtamine medically directed by Dr. Jeffrey Lyvers, MD and operated by Elizabeth Lyvers, DNP, CRNA. Dr. Lyvers is a board certified anesthesiologist and critical care physician.